eVisit, a key virtual care transformation partner for health systems, has acquired inpatient teleconsult technology from UPMC.
This move significantly broadens eVisit's inpatient telehealth services, reinforcing its position in the healthcare sector for both ambulatory and inpatient settings.
Additionally, eVisit has secured strategic investments from UPMC Enterprises and MedStar Health, complementing a $45m Series B funding round led by Goldman Sachs Asset Management.
UPMC Enterprises is UPMC's innovation, commercialisation and venture capital arm.
The investments will foster co-development opportunities and further integrate representatives from both organisations into eVisit's Clinical Advisory Board.
UPMC Enterprises executive vice-president Brent Burns said: “Our guiding mission at UPMC Enterprises is to develop solutions to the clinical needs identified by the thousands of physicians at UPMC who provide lifesaving care to our patients.
“When we create something like the teleconsult technology that so brilliantly achieves that goal and becomes a vital part of our clinical operations, we look for partners who can help us make it available to clinicians and patients outside our walls.”
Developed by UPMC during the early phase of the Covid-19 pandemic in 2020, the technology facilitates virtual consultations with clinical specialists, streamlining inpatient care across multiple services, including stroke and critical care.
The platform has delivered 40,000 consults to date, achieving a 92% reduction in patient wait times.
UPMC Enterprises Technology Services will also contribute technology advisory services to eVisit.
UPMC Enterprises senior medical advisor Andrew Watson will join eVisit's Clinical Advisory Board.
MedStar has a longstanding relationship with eVisit and has been utilising its technologies since 2018.
The company has progressed from teletriage and provider consultations to scheduled telehealth visits and, more recently, managing a regional infectious disease treatment hub with eVisit's technology.
